171 related articles for article (PubMed ID: 12704530)
1. Innovative therapies in wound healing.
Shen JT; Falanga V
J Cutan Med Surg; 2003; 7(3):217-24. PubMed ID: 12704530
[TBL] [Abstract][Full Text] [Related]
2. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
Curran MP; Plosker GL
BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
[TBL] [Abstract][Full Text] [Related]
3. A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers.
Zaulyanov L; Kirsner RS
Clin Interv Aging; 2007; 2(1):93-8. PubMed ID: 18044080
[TBL] [Abstract][Full Text] [Related]
4. Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf).
Karr JC
Adv Skin Wound Care; 2011 Mar; 24(3):119-25. PubMed ID: 21326023
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers.
Langer A; Rogowski W
BMC Health Serv Res; 2009 Jul; 9():115. PubMed ID: 19591680
[TBL] [Abstract][Full Text] [Related]
6. Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes.
Barber C; Watt A; Pham C; Humphreys K; Penington A; Mutimer K; Edwards M; Maddern G
J Wound Care; 2008 Dec; 17(12):517-27. PubMed ID: 19052516
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost.
Zelen CM; Serena TE; Gould L; Le L; Carter MJ; Keller J; Li WW
Int Wound J; 2016 Apr; 13(2):272-82. PubMed ID: 26695998
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of Apligraf in the treatment of diabetic foot ulcers.
Dinh TL; Veves A
Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):152S-157S; discussion 158S-159S. PubMed ID: 16799383
[TBL] [Abstract][Full Text] [Related]
9. Tissue engineered skin: Apligraf, a bi-layered living skin equivalent.
Trent JF; Kirsner RS
Int J Clin Pract; 1998 Sep; 52(6):408-13. PubMed ID: 9894378
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers.
Zelen CM; Gould L; Serena TE; Carter MJ; Keller J; Li WW
Int Wound J; 2015 Dec; 12(6):724-32. PubMed ID: 25424146
[TBL] [Abstract][Full Text] [Related]
11. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers.
Cavorsi J; Vicari F; Wirthlin DJ; Ennis W; Kirsner R; O'Connell SM; Steinberg J; Falanga V
Wound Repair Regen; 2006; 14(2):102-9. PubMed ID: 16630097
[TBL] [Abstract][Full Text] [Related]
12. Utilization of living bilayered cell therapy (Apligraf) for heel ulcers.
Karr J
Adv Skin Wound Care; 2008 Jun; 21(6):270-4. PubMed ID: 18525250
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study.
Hu S; Kirsner RS; Falanga V; Phillips T; Eaglstein WH
Wound Repair Regen; 2006; 14(4):427-33. PubMed ID: 16939570
[TBL] [Abstract][Full Text] [Related]
14. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing.
Brem H; Balledux J; Bloom T; Kerstein MD; Hollier L
Arch Surg; 2000 Jun; 135(6):627-34. PubMed ID: 10843357
[TBL] [Abstract][Full Text] [Related]
15. The use of Apligraf in acute wounds.
Kirsner RS
J Dermatol; 1998 Dec; 25(12):805-11. PubMed ID: 9990773
[TBL] [Abstract][Full Text] [Related]
16. Experience with the use of apligraf to heal complicated surgical and nonsurgical wounds in a private practice setting.
Shealy FG; DeLoach ED
Adv Skin Wound Care; 2006; 19(6):310-22. PubMed ID: 16885645
[TBL] [Abstract][Full Text] [Related]
17. Apligraf treatment of venous ulcers and other chronic wounds.
Falanga V
J Dermatol; 1998 Dec; 25(12):812-7. PubMed ID: 9990774
[No Abstract] [Full Text] [Related]
18. The FDA and designing clinical trials for chronic cutaneous ulcers.
Maderal AD; Vivas AC; Eaglstein WH; Kirsner RS
Semin Cell Dev Biol; 2012 Dec; 23(9):993-9. PubMed ID: 23063664
[TBL] [Abstract][Full Text] [Related]
19. Emerging Trends in Therapeutic Algorithm of Chronic Wound Healers: Recent Advances in Drug Delivery Systems, Concepts-to-Clinical Application and Future Prospects.
Shao M; Hussain Z; Thu HE; Khan S; de Matas M; Silkstone V; Qin HL; Bukhari SNA
Crit Rev Ther Drug Carrier Syst; 2017; 34(5):387-452. PubMed ID: 29256838
[TBL] [Abstract][Full Text] [Related]
20. Cultured skin as a 'smart material' for healing wounds: experience in venous ulcers.
Sabolinski ML; Alvarez O; Auletta M; Mulder G; Parenteau NL
Biomaterials; 1996 Feb; 17(3):311-20. PubMed ID: 8745328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]